Source: Eur Respir Monogr 2020; 87: 138-154
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
David T. Arnold, Mark Roberts, Momen Wahidi, Rahul Bhatnagar. Optimal diagnosis and treatment of malignant pleural disease: challenging the guidelines. Eur Respir Monogr 2020; 87: 138-154

Member's Comments

No comment yet.

Related content which might interest you: Optimal management of symptomatic malignant pleural effusions: individualised care Source: Virtual Congress 2021 – Hot news from the pleura Year: 2021 ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma Source: Guideline 2020 Year: 2020 ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma Source: Eur Respir J, 55 (6) 1900953; 10.1183/13993003.00953-2019 Year: 2020 Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment Source: Eur Respir Rev 2016; 25: 472-486 Year: 2016 Malignant pleural effusions: from the diagnosis to the management Source: International Congress 2015 – ME2 Malignant pleural effusions: from diagnosis to management Year: 2015 Malignant pleural effusions: diagnosis and management Source: International Congress 2017 – PG5 Pleural disease management Year: 2017 The impact of multimodal treatment approaches in patients with malignant pleural mesothelioma Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010 ERS/EACTS statement on the management of malignant pleural effusions Source: Guideline 2018 Year: 2018 ERS/EACTS statement on the management of malignant pleural effusions Source: Eur Respir J, 52 (1) 1800349; 10.1183/13993003.00349-2018 Year: 2018 Multimodal management of malignant pleural mesothelioma: where are we today? Source: Eur Respir J 2014; 44: 754-764 Year: 2014 Are patients with malignant pleural effusions being referred appropriately for surgical intervention? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 Immunotherapy for malignant pleural mesothelioma: ready for clinical practice? Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies? Year: 2016 Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management Source: Eur Respir J 2016; 47: 45-68 Year: 2016 Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management Source: Guideline 2016 Year: 2016 Recurrent pleural effusion : algorithm for diagnosis and treatment Source: Annual Congress 2004 - PG20 - State-of-the art in management of pleural diseases Year: 2004 How often is a single therapeutic aspiration sufficient to manage a malignant pleural effusion and does oncological treatment have an impact on this? Source: International Congress 2019 – Pleural disease: applying the evidence Year: 2019 The pathologist needs for diagnosis of pleural disease Source: Hands-on Course 2012 - Medical Thoracoscopy Year: 2012 Advanced medical interventions in pleural disease Source: Eur Respir Rev 2016; 25: 199-213 Year: 2016 Algorithm for diagnostics of recurrent pleural effusions suspected to malignancy Source: Eur Respir J 2006; 28: Suppl. 50, 88s Year: 2006